Combined approach with therapeutic drug monitoring and pharmacogenomics in renal transplant recipients
In patients undergoing renal transplantation, dose individualization for tacrolimus is routinely achieved with therapeutic drug monitoring (TDM). The patient started on 5.5 mg/day of tacrolimus had a significantly elevated tacrolimus trough concentration. The tacrolimus dose was regularly reduced fo...
Main Authors: | S Manvizhi, B S Mathew, D H Fleming, G Basu, G T John |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Indian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2013;volume=23;issue=1;spage=71;epage=73;aulast=Manvizhi |
Similar Items
-
Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01) -
Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01) -
Influence of CYP3A5 and ABCB1 polymorphism on tacrolimus drug dosing in South Indian renal allograft recipients
by: M Edwin Fernando, et al.
Published: (2019-01-01) -
Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017-03-01) -
Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study
by: Giovanni Pallio, et al.
Published: (2020-06-01)